SCAI 2021: Pattern of TAVR Program Growth & Inequities in Access
With the notion that inequitable diffusion of new technologies in areas with high socioeconomic...
Read MoreMay 4, 2021
With the notion that inequitable diffusion of new technologies in areas with high socioeconomic...
Read MoreMay 3, 2021
In July 2020, experts participated in individual semi-structured qualitative interviews about how tardive Dyskinesia (TD) is diagnosed and treated in real-world settings. A virtual roundtable follow-up was conducted in November...
Read MoreMay 3, 2021
Researchers presented the findings of cognitive behavioral therapy (CBT) benefits on anxiety, depression, and quality of life in patients with mild cognitive impairment (MCI) and dementia “Today, no reviews have analyzed...
Read MoreMay 2, 2021
By: Chirag Shah; Shereta Wiley; Sylvie Stacy; Leslie Lundt In a poster session, researchers sought to understand the evolving continuing medical education (CME) needs of psychiatrists managing patients with tardive dyskinesia...
Read MoreMay 2, 2021
As an involuntary movement disorder resulting from exposure to dopamine antagonists, tardive dyskinesia (TD) classically manifests as involuntary oro-bucco-lingual and facial dyskinesia, as well as limb, trunk, and respiratory...
Read MoreMay 1, 2021
There is growing number of treatment-refractory patients in psychiatric practice. Although evidence-based treatments may be effective in most patients, there is a significant number of psychiatric patients, who may not have an...
Read MoreMay 1, 2021
Data from the real-world RE-KINECT study were analyzed to better understand the impact of tardive dyskinesia (TD) on wellbeing and health state in patients who are aware of their TD. Over 200 adults with over 3 months of...
Read MoreApr 30, 2021
This Year’s Theme: Finding Equity Through Advances in Mind & Brain in Unsettled Times...
Read MoreApr 30, 2021
A year since COVID-19 was declared a worldwide emergency, experts warn that a subsequent mental health pandemic is imminent, due to the lasting adverse impacts of stress, anxiety and isolation. This year’s Annual Meeting offers...
Read MoreApr 30, 2021
Friday, April 30, 2021 11:00 a.m. – 5:30 p.m. ET Pre-Conference Expo Virtual Exhibit Gallery Product Theater Showcases Saturday, May 1, 2021 10:00 a.m. – 11:00 a.m. ET Opening Session (Plenary), Featuring Keynote Speaker Isabel...
Read MoreApr 30, 2021
Schedule Friday, April 30, 2021 Noon – 1:00 p.m. ET Supported by Axsome Therapeutics Inc. [Product Theater 1] New Pathways in Depression: Potential to Improve Clinical Outcomes Roger S. McIntyre MD, FRCP Professor of...
Read MoreApr 30, 2021
APA is pleased to announce that Anthony Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases will deliver the 2021 William C. Menninger Memorial Convocation Lecture on May 2. At NIAID, Fauci...
Read MoreApr 29, 2021
Prof. Tony Traboulsee talks to Physician’s Weekly about his study of tolebrutinib Presented at the...
Read MoreApr 28, 2021
Recommendations still oppose pregnancy during MS therapy Women with relapsing multiple sclerosis...
Read MoreApr 28, 2021
Reduction in lesion activity seen as early as 8 weeks Patients diagnosed with relapsing...
Read MoreApr 27, 2021
Although the CheckMate-9ER trial, comparing cabozantinib plus nivolumab to sunitinib in frontline metastatic renal cell carcinoma (mRCC), had recently demonstrated improved progression-free survival (PFS) and overall survival...
Read MoreApr 26, 2021
Patients with hidradenitis suppurativa were asked about their satisfaction regarding telemedicine...
Read MoreApr 26, 2021
First author: Niki Nourmohammadi The COVID-19 pandemic has been associated with psychological...
Read MoreApr 26, 2021
Presented by: Prof. Mario Lacouture, Memorial Sloan Kettering Cancer Centre As advances in breast...
Read More